[{"data": {"name": "Evaluating Global Early Market Access Opportunities For Innovative Therapies: Focus On Japan, Uk And Us", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "D.R. Carr", "@type": "Person"}, {"name": "E. Anastasaki", "@type": "Person"}, {"name": "S.E. Bradshaw", "@type": "Person"}], "license": "elsevier-specific: oa user license", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://www.valueinhealthjournal.com/article/S1098301515006221/pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Elsevier BV", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1016/j.jval.2015.03.565", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCjnrRCVB8swn-CTPtJjuRGpYpA-CDAUmumypgnJZ-CRjEfBckSs3ip", "propertyID": "ISCC"}], "datePublished": "2015-05-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]